Pharma stock engaged in dealing, marketing, and manufacturing rubber contraceptives and allied prophylactic products hit a 5 percent upper circuit upon declaring robust results with a 284 percent jump in Net Profits.
Price Action
With a market capitalization of Rs. 2,575 Crores, the shares of Cupid Limited hit a 5 percent upper circuit at Rs. 95.99 per equity share, from its previous day’s close price of Rs. 91.42 It has delivered multibagger returns of 570 percent in a year.
Q1FY25 Results
Its Revenue from operations grew by 16 percent YoY from Rs. 33.67 Crores in Q1FY24 to Rs. 39.13 Crores in Q1FY25 and it declined by 37 percent QoQ from Rs. 62.89 Crores in Q4FY24 to Rs. 39.13 Crores in Q1FY25.
Its Net Profit grew by 284 percent YoY from Rs. 2.15 Crores in Q1FY24 to Rs. 8.25 Crores in Q1FY25 and it declined by 65 percent QoQ from Rs. 23.71 Crores in Q4FY24 to Rs. 8.25 Crores in Q1FY25. Its Net Profit Margin increased from 6.38 percent in Q1FY24 to 18.70 percent in Q1FY25.
In Q1FY25 there was a growth of 5 percent YoY in the sales of Male and Female Contraceptives & Jelly from Rs. 33.52 Crores to Rs. 35.11 Crores and the sales of In Vitro Devices grew by 961 percent YoY from Rs. 14.98 Lakhs to Rs. 1.58 Crores.
Also read
Management Comments
Commenting on the results, Mr Aditya Kumar Halwasiya, Managing Director said, “We are delighted to announce a good set of numbers for the quarter. We have continued to bring in efficiencies in overall production and domestic distribution.
The Company’s foray into B2C in India in the last seven months has resulted in net revenues of Rs. 12.50 crore and we are going to expand this pie substantially moving forward. The improved margins are very well maintainable in the long run. Once the additional capacities are up and running with matching orders from across the World, we will further get the benefit of the scale of operations.
As a part of our Indian B2C expansion, we have built our presence across over 50,000 retail touch points in a short span of time and are on the horizon to reach 1,00,000 touch points by the end of the current calendar year.
We are prioritizing our brand expansion by initially focusing on general trade and then modern trade in the domestic market. Internationally we would continue to seek
opportunities to expand our brand presence through partnerships with distributors that have a strong presence in their respective markets.”
About the Company
Cupid Limited is engaged in the business of dealing, marketing, and manufacturing rubber contraceptives and allied prophylactic products under the brand name Cupid. It is one of India’s premier manufacturer of male and female condoms, waterbased lubricant jelly, IVD
Cupid Limited boasts a production capacity of up to 480 million male condoms, 52 million female condoms, 210 million sachets of lubricant jelly, and 20 million IVD Test Kits annually
Cupid Limited’s 94 percent of sales come from exports and the rest 6 percent comes from domestic sales. The product-wise sales breakdown includes 75 percent sales of male condoms, 16 percent from female condoms, and 9 percent from Lubricant Jelly kits and Deodorants.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
